P
Purple Biotech Ltd
NASDAQ:PPBT
Purple Biotech Ltd
NASDAQ:PPBT
Price:
4.23
USD
2.42%
Market Cap:
$143.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Purple Biotech Ltd
NASDAQ:PPBT
|
IL |
|
K
|
KSG Agro SA
WSE:KSG
|
UA |
|
Aegis Brands Inc
TSX:AEG
|
CA |
|
Mister Spex SE
XETRA:MRX
|
DE |
|
C
|
Cowell e Holdings Inc
HKEX:1415
|
CN |
|
Agf A/S
CSE:AGF B
|
DK |
|
Seazen Group Ltd
HKEX:1030
|
CN |
|
O
|
OY Nofar Energy Ltd
TASE:NOFR
|
IL |
|
A
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
SET:AIMIRT
|
TH |
|
E
|
EROAD Ltd
ASX:ERD
|
NZ |
|
Kaluzhskaya Sbytovaya Kompaniya PAO
MOEX:KLSB
|
RU |
|
Artson Engineering Ltd
BSE:522134
|
IN |
|
D
|
DavoLink Inc
KOSDAQ:340360
|
KR |
|
BW LPG Ltd
OSE:BWLPG
|
SG |
|
G
|
Georg Fischer AG
LSE:0QP4
|
CH |
Balance Sheet
Balance Sheet Decomposition
Purple Biotech Ltd
Purple Biotech Ltd
Balance Sheet Decomposition is not available for
Purple Biotech Ltd
Purple Biotech Ltd
Balance Sheet
Purple Biotech Ltd
Purple Biotech Ltd
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
11
|
7
|
4
|
5
|
4
|
11
|
11
|
15
|
14
|
7
|
|
| Cash Equivalents |
0
|
0
|
1
|
11
|
7
|
4
|
5
|
4
|
11
|
11
|
15
|
14
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
8
|
3
|
2
|
2
|
47
|
36
|
17
|
1
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
2
|
11
|
15
|
8
|
9
|
8
|
59
|
48
|
33
|
16
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
20
|
20
|
21
|
28
|
28
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+3 788%
|
2
+466%
|
11
+515%
|
15
+38%
|
14
-5%
|
15
+4%
|
15
0%
|
84
+469%
|
70
-16%
|
55
-22%
|
44
-19%
|
37
-16%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
2
|
4
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
0
|
3
|
0
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
5
|
0
|
1
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
1
|
4
|
3
|
4
|
3
|
4
|
7
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+203%
|
1
-22%
|
1
+40%
|
2
+11%
|
7
+343%
|
4
-38%
|
4
+2%
|
4
+3%
|
5
+22%
|
8
+44%
|
10
+31%
|
4
-59%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
4
|
8
|
13
|
17
|
29
|
34
|
37
|
40
|
59
|
79
|
99
|
115
|
|
| Additional Paid In Capital |
1
|
3
|
9
|
22
|
31
|
36
|
45
|
47
|
119
|
124
|
126
|
133
|
148
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
-132%
|
1
N/A
|
9
+1 120%
|
13
+42%
|
7
-45%
|
11
+42%
|
10
-1%
|
79
+662%
|
65
-18%
|
47
-28%
|
34
-27%
|
33
-4%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+3 788%
|
2
+466%
|
11
+515%
|
15
+38%
|
14
-5%
|
15
+4%
|
15
0%
|
84
+469%
|
70
-16%
|
55
-22%
|
44
-19%
|
37
-16%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
4
|
8
|
11
|
16
|
20
|
172
|
178
|
185
|
252
|
517
|
|
Switch to:
Switch to:
See Also
Discover More
